The standard of care for non-invasive management of heart transplant recipients.
Heart Allograft Surveillance test service is a non-invasive gene expression profile test of peripheral blood in heart transplant recipients.
The test is a panel of 11 informative genes and 9 controlled genes. It detects changes in gene expression associated with acute rejection and provides an actionable score.
About Gene Expression Profiling
The assay detects changes in gene expression of peripheral blood cells for 11 genes involved in the immune response. These genes were selected and validated for their association with acute cellular rejection in heart transplant patients.
Recommended in ISHLT guidelines and used in over 90% of transplant centers.
